Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS3-007a dry suspension in pediatric growth hormone deficiency and idiopathic short stature
CTR20254674Phase 2Active
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GS3-007 in growth hormone deficiency (GHD), Idiopathic Short Stature (ISS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Jun 2026; status: active.
02
Drugs
GS3-007
03
Conditions
growth hormone deficiency (GHD)Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on CTR20254674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254674.